JEFFREY DEMPSEY: Open Payments
NPI 1063282549 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,509 in 123 payments from 35 companies in 2025. Trend: 2023 $0 · 2024 $1,727 · 2025 $4,509
Food & beverage: $3,567Travel & lodging: $942
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 15 | $1,498 |
| Novo Nordisk Inc | 18 | $285 |
| Corcept Therapeutics | 7 | $234 |
| AstraZeneca Pharmaceuticals LP | 4 | $208 |
| Axsome Therapeutics, Inc. | 5 | $205 |
| SANOFI-AVENTIS U.S. LLC | 4 | $185 |
| Lilly USA, LLC | 12 | $182 |
| Amgen Inc. | 4 | $172 |
| Dexcom, Inc. | 3 | $164 |
| Stryker Corporation | 2 | $146 |
Products named: MINIMED 780G, Korlym, Auvelity, TZIELD, Dexcom G6 Transmitter, MOUNJARO, Ozempic, MAKO.
Industry payments across TX — which companies pay providers there.
